logologo
QuantliQuantli

Oric Pharmaceuticals Inc

ORIC

NASDAQ

Biotechnology

$13.87

USD

+0.15 (+1.09%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $1.42B

Volume 828.5K

Price Target

$27.00$27.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $27.00 and a min estimate of $27.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$27.00

+$8.8 vs prior

Implied Upside

+94.7%

+63.1% vs prior

Analyst Covering

1

-3 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

20%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Robert Burns

HC Wainwright & Co.

Buy

Maintained

5 days ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AKTS

Aktis Oncology Inc

$24.93

+4.8%

AVBP

ArriVent BioPharma Inc

$29.51

-1.6%

PURR

Hyperliquid Strategies Inc

$6.68

-2.0%

INBX

Inhibrx Biosciences Inc

$88.37

-8.9%

CGEM

Cullinan Therapeutics Inc

$20.34

+3.6%

TYRA

Tyra Biosciences Inc

$25.29

+1.1%

ABSI

Absci Corp

$9.18

-3.0%

NVAX

Novavax Inc

$8.05

-1.1%

GLUE

Monte Rosa Therapeutics Inc

$15.50

-2.1%

VIR

Vir Biotechnology Inc

$9.24

+2.7%